Intravenous vitamin therapy and the line between a supplement and a medicine
The same bag of vitamins can be lawful or unlawful depending entirely on what is said about it.
Key takeaways
- Under EU law, a product can be a medicinal product by presentation, not only by composition.
- Intravenous vitamin preparations promoted for therapeutic effects require a marketing authorisation.
- There is no good trial evidence that IV vitamin mixtures improve health in non-deficient people.
- Intravenous administration carries risks that oral supplementation does not.
Infusion lounges have become a fixture of the international wellness market, from airport concourses to hotel suites, offering vitamin mixtures delivered by drip under names borrowed from cocktails. The commercial logic is obvious. The legal position is stranger than most of the people involved appear to realise, and it does not turn on pharmacology at all.
Under EU law a product is a medicinal product by presentation if it is presented as having properties for treating or preventing disease in human beings. Presentation alone is sufficient. The composition of the preparation is not the deciding factor; the sentence written beside it is. A medicinal product requires a marketing authorisation, and manufacture and administration fall under a separate regulatory regime from food.
In July 2026 the Greek medicines agency set this out explicitly for the sector. Its position was that intravenous preparations promoted for detoxification, anti ageing, weight loss or immune support are not food supplements; that anything intended for intravenous administration and presented with therapeutic properties is a medicinal product requiring authorisation; and that liability extends to anyone participating directly or indirectly in its promotion or administration, which reaches the venue, the marketer and the person holding the cannula, not only the importer.
The result is a regime that can look arbitrary from inside the industry. An identical bag, in an identical room, is one thing when nothing is claimed for it and another once the website says it restores, detoxifies or reverses. What the evidence does not support, separately from the law, is the underlying premise: there is no good trial evidence that intravenous vitamin mixtures improve health, energy, immunity or ageing in people who are not deficient, and intravenous administration is not a benign delivery route simply because the contents are nutrients. The regulatory question and the efficacy question happen to point the same way here, but they are being asked by different people for different reasons.
Notes and sources
Each regulatory statement in this article is set against the document it comes from, so you can read the original rather than our summary of it.
1. Definition of a medicinal product, including by function and by presentation
Directive 2001/83/EC on the Community code relating to medicinal products for human use
2. A medicinal product requires a marketing authorisation before being placed on the market
3. Regulatory warnings about intravenous vitamin infusions marketed for wellness
FDA warning letters and consumer updates on unapproved intravenous products
